33. Walsh JM et al. Barriers to colorectal cancer screening in Latino and Vietnamese Americans. Compared with non-Latino white Americans..
34. Perez-Stable EJ et al. Self-reported use of cancer screening tests among Latinos and Anglos in a prepaid health plan..
35. Shariff-Marco S et al. Racial/ethnic differences in self-reported racism and its association with cancer-related health behaviors..
36. Powe BD et al. Comparing knowledge of colorectal and prostate cancer among African American and Hispanic men..
37. Jun J, Oh KM. Asian and Hispanic Americans’ cancer fatalism and colon cancer screening..
38. Hacker K et al. The impact of Immigration and Customs Enforcement on immigrant health: Perceptions of immigrants in Everett, Massachusetts, USA..
39. Firger J. Rescinding DACA could spur a public health crisis, from lost services to higher rates of depression, substance abuse..
40. May FP et al. Racial minorities are more likely than whites to report lack of provider recommendation for colon cancer screening..
41. Levy BT et al. Why hasn’t this patient been screened for colon cancer? An Iowa Research Network study..
42. Rosenblatt RA. A view from the periphery – health care in rural America..
43. Young WF et al. Predictors of colorectal screening in rural Colorado: testing to prevent colon cancer in the high plains research network..
44. Kates J et al. Health and Access to Care and Coverage for Lesbian, Gay, Bisexual, and Transgender (LGBT) Individuals in the U.S. In:.
45. Katz ML et al. Improving colorectal cancer screening by using community volunteers: results of the Carolinas cancer education and screening (CARES) project..
46. Jean-Jacques M et al. Program to improve colorectal cancer screening in a low-income, racially diverse population: A randomized controlled trial..
47. Reuland DS et al. Effect of combined patient decision aid and patient navigation vs usual care for colorectal cancer screening in a vulnerable patient population: A randomized clinical trial..
48. Percac-Lima S et al. A culturally tailored navigator program for colorectal cancer screening in a community health center: a randomized, controlled trial..
49. Nash D et al. Evaluation of an intervention to increase screening colonoscopy in an urban public hospital setting..
50. Lebwohl B et al. Effect of a patient navigator program on the volume and quality of colonoscopy..
51. Khankari K et al. Improving colorectal cancer screening among the medically underserved: A pilot study within a federally qualified health center..
52. Wang JH et al. Recruiting Chinese Americans into cancer screening intervention trials: Strategies and outcomes..
53. Katz ML et al. Patient activation increases colorectal cancer screening rates: a randomized trial among low-income minority patients..
54. Ford ME et al. Enhancing adherence among older African American men enrolled in a longitudinal cancer screening trial..
55. Christie J et al. A randomized controlled trial using patient navigation to increase colonoscopy screening among low-income minorities..
56. Philip EJ et al. Evaluating the impact of an educational intervention to increase CRC screening rates in the African American community: A preliminary study..
57. Greiner KA et al. Implementation intentions and colorectal screening: A randomized trial in safety-net clinics..
58. Horne HN et al. Effect of patient navigation on colorectal cancer screening in a community-based randomized controlled trial of urban African American adults..
59. Grubbs SS et al. Eliminating racial disparities in colorectal cancer in the real world: It took a village..
60. Jung MY et al. The Chinese and Korean American immigrant experience: a mixed-methods examination of facilitators and barriers of colorectal cancer screening..
61. Viruell-Fuentes EA et al. More than culture: structural racism, intersectionality theory, and immigrant health..
Dr. Oduyebo is a third-year fellow at the Mayo Clinic, Rochester, Minn.; Dr. Malespin is an assistant professor in the department of medicine and the medical director of hepatology at the University of Florida Health, Jacksonville; Dr. Mendoza Ladd is an assistant professor of medicine at Texas Tech University, El Paso; Dr. Day is an associate professor of medicine at the University of California, San Francisco; Dr. Charabaty is an associate professor of medicine and the director of the IBD Center in the division of gastroenterology at Medstar-Georgetown University Center, Washington; Dr. Chen is an associate professor of medicine, the director of patient safety and quality, and the director of the small-bowel endoscopy program in division of gastroenterology at Washington University, St. Louis; Dr. Carr is an assistant professor of medicine in the division of gastroenterology at the University of Pennsylvania, Philadelphia; Dr. Quezada is an assistant dean for admissions, an assistant dean for academic and multicultural affairs, and an assistant professor of medicine in the division of gastroenterology and hepatology at the University of Maryland, Baltimore; and Dr. Lamousé-Smith is a director of translational medicine, immunology, and early development at Janssen Pharmaceuticals Research and Development, Spring House, Penn.